FBXW11 and cancer: In four cancers, mutations at the N-terminal disordered region of the protein are predicted to perturb interactions with BTRC, FBXW11 and HLA-A, whereas only two of these cancers (liver cancers) have additional mutations at the armadillo region perturbing interactions with other proteins (Fig. S5).